Nuveen, LLC Legend Biotech Corp Call Options Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LEGN
# of Institutions
232Shares Held
85.6MCall Options Held
316KPut Options Held
374K-
Ra Capital Management, L.P. Boston, MA7.51MShares$243 Million3.96% of portfolio
-
Westfield Capital Management CO LP Boston, MA6.92MShares$224 Million1.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$220 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$194 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$185 Million0.01% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.42B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...